Promoter holding
64.27%
PL
Parnax Lab Limited - Due diligence report
A 360° intelligence report on Parnax Lab: trust score, financial health, credit view, compliance, directors, growth and distress signals - g…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Parnax Lab — 360° Intelligence Report
Generated from MCA filings & public records68/100
Trust Score
Moderate
Parnax Lab is assessed as Moderate with a Trust Score of 68/100. Parnax Lab is an active public limited indian non-government company incorporated in 1982, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Parnax Lab Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
68/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
55/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
65/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
75/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 65/100 Moderate
- Profitable - internal accruals available.
Charges position: 6 open (24.20 cr) · 3 satisfied (4.66 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| State Bank Of India | 6 | 48.0 cr |
| Others | 1 | 48.0 cr |
| Maratha Sahakari Bank Ltd | 2 | 48.0 cr |
Compliance Score: 55/100 Moderate
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Flagged by authority: RBI, BSE, SEBI.
- Litigation present in 1 court forum(s).
- Delayed payments to MSME suppliers disclosed (27 disclosure(s)).
- 2 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 75/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| VIJAYKUMAR SHIVAJI AYARE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| HARISH SUNDERLAL PANPALIA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MIHIR PRAKASH SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| YOGESH KANTILAL VARIA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PREET VIJAY KUKREJA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| TIRUNILLAI VENKATESWARA ANATHARAMAN | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BINOY BAIJU SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| AMI MIHIR SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Mihir Prakash Shah | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Binoy Baiju Shah | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 10 directors on the board.
- No disqualified or deactivated DINs.
- 5 director exits in 3 years - high churn.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
2 allotment(s) · 0 transfer(s)
Promoters hold a minority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Naxpar Pharma Private Limited | Subsidiary Company | 74.00% |
Key managerial personnel: MIHIR PRAKASH SHAH (CEO) · BINOY BAIJU SHAH (CFO)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 85 · Distress 65
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Profit expanded 1.42 year-on-year.
Net margin improved to 2.1x.
Operating for 43+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
3 director exits within 2 years.
Compliance score is weak (55/100).
6 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 51.56 Lakh.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence62/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment62/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 6 open charge(s) of 24.20 cr already registered.
- Compliance gaps should be priced into terms.
Investor view74/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events29 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
20 Mar 2025
Director ceased
VIJAYKUMAR SHIVAJI AYARE
10 Feb 2025
Director appointed
VIJAYKUMAR SHIVAJI AYARE (Director)
13 Nov 2024
Director ceased
MIHIR PRAKASH SHAH
Director ceased
BINOY BAIJU SHAH
03 Aug 2024
Director appointed
Mihir Prakash Shah (Ceo)
Director appointed
Binoy Baiju Shah (Cfo)
05 Jul 2024
Director appointed
MIHIR PRAKASH SHAH (CEO)
Director appointed
BINOY BAIJU SHAH (CFO)
18 Jun 2024
Charge satisfied
Others
31 Mar 2024
Director ceased
VINAYAK BABLI DESAI
28 Sep 2023
Director ceased
HARISH SUNDERLAL PANPALIA
11 Aug 2023
Director appointed
HARISH SUNDERLAL PANPALIA (Director)
30 Sep 2021
Director ceased
YOGESH KANTILAL VARIA
10
Key Observations
Auto-generated from the data aboveRevenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
10 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
Promoters hold a minority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Norris Medicines | L24230GJ1990PLC086581 | Ankleshwar, Gujarat, India |
| Dream Green Petro-Chem Private Limited | U24296MH2014PTC252999 | Nashik, Maharashtra, India |
| Colinz Laboratories | L24200MH1986PLC041128 | Mumbai, Maharashtra, India |
| Meek Pharma Private Limited | U24230UR2005PTC000876 | Rudrapur, Uttarakhand, India |
| Neoanthem Lifesciences Private Limited | U24239KA2020PTC136337 | Bengaluru, Karnataka, India |
| Wilber | U24100KA2018PTC117944 | Jigani, Karnataka, India |
| Detailing Devils India Private Limited | U74999DL2017PTC323499 | Delhi, Delhi, India |
| Asli Ayurveda Wellness Private Limited | U15400HR2020PTC089113 | Karnal, Haryana, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Parnax Lab before audits and certifications: compliance score 55/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Parnax Lab: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 85/100, margin trends, ownership structure and peer set for Parnax Lab - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 68/100, distress signals and MSME payment-delay disclosures - know whether Parnax Lab pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Parnax Lab - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Parnax Lab an active company?
Parnax Lab has MCA status “Active” with a compliance score of 55/100 (Moderate).
Is Parnax Lab financially healthy?
Parnax Lab has a Financial Health Score of 65/100 (Moderate) based on its filed financial statements.
Should I do business with Parnax Lab?
Its overall Trust Score is 68/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Parnax Lab?
Promoters hold a minority stake - exact percentages are in the full report. 10 active director(s) are on record.
Does Parnax Lab have loans or charges against its assets?
6 open charge(s) are registered against its assets, and 3 earlier charge(s) stand satisfied.
Is Parnax Lab up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 55/100 (Moderate).
Is it risky to lend to Parnax Lab?
Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
